AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 293: L1219-L1229, 2007. First published August 31, 2007; doi:10.1152/ajplung.00083.2007
1040-0605/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/L1219    most recent
00083.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gertzberg, N.
Right arrow Articles by Johnson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gertzberg, N.
Right arrow Articles by Johnson, A.

Tumor necrosis factor-{alpha} causes barrier dysfunction mediated by tyrosine198 and tyrosine218 in beta-actin

Nancy Gertzberg,1,2 Tina Gurnani,3 Paul Neumann,1,2 Anne-Kay Forbes,4 Natacha Jean-Louis,4 and Arnold Johnson1,2

1Department of Pharmaceutical Science, Albany College of Pharmacy; 2Research Service of the Stratton Veterans Affairs Medical Center; 3Albany Medical College; and 4State University of New York at Albany, Albany, New York

Submitted 6 March 2007 ; accepted in final form 21 August 2007

We tested the hypothesis that tumor necrosis factor-{alpha} (TNF) induces barrier dysfunction of pulmonary microvessel endothelial monolayers (PMEM) mediated by specific tyrosine residues in beta-actin. PMEM were transfected with a wild-type, mutant [tyrosine198 to phenylalanine198 (Y198F)], mutant Y218F, or mutant Y306F beta-actin construct tagged with enhanced yellow fluorescent protein (EYFP-beta-actin). The cellular compartmentalization of wild-type and mutant EYFP-beta-actin was displayed using EYFP fluorescence of the tagged beta-actin. beta-Actin was quantified for the EYFP-tagged and native beta-actin using Western blot assay. The effect of the EYFP-beta-actin on a cell junction protein was assessed by association of EYFP-beta-actin with beta-catenin using confocal microscopy and coimmunoprecipitation. The permeability of PMEM was assessed by the clearance rate of Evans blue-labeled albumin. The cellular compartmentalization of wild-type and mutant EYFP-beta-actin was similar to the native beta-actin. Incubation of PMEM with TNF (100 ng/ml) for 0.5 h resulted in increases in permeability to albumin and a decrease in association of the EYFP-beta-actin with beta-catenin. However, the expression of the EYFP-Y198F beta-actin and EYFP-Y218F beta-actin prevented the effect of TNF on beta-catenin and barrier function. The vehicle, wild-type EYFP-beta-actin, and mutant Y306F beta-actin had no affect on the response to TNF. The data indicate that TNF induces an increase in endothelial permeability that is dependent on tyrosine198 and tyrosine218 in beta-actin.

edema; permeability; nitration



Address for reprint requests and other correspondence: A. Johnson, 106 New Scotland Ave., OB 104J, Albany College of Pharmacy, Albany, NY 12208 (e-mail: johnsona2{at}acp.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.